Your Health, We Care
Release date: 2024-08-22 17:35:48 Recommended: 129
Alpelisib is a drug for the treatment of HR/HER2- breast cancer, especially for patients with PIK3CA mutations; Inhibits tumor proliferation by blocking the PI3K pathway.
The prices of the different versions of Alpelisib are as follows:
Laos Lucius version 150mg*28 tablets about 1755 yuan, India export version 200mg*14 capsules and 150mg*28 tablets about 3900 yuan, Hong Kong export version 150mg*56 tablets about 43800 yuan.
The above prices are for reference only. When purchasing medicines, patients should choose according to their own financial situation and doctors' recommendations, and choose formal channels. It is recommended to buy at a reputable large pharmacy or medical institution to avoid buying counterfeit and shoddy products.
For the use of drugs in special populations, special attention needs to be paid to some specific requirements and restrictions.
When dealing with medication in special populations, special attention needs to be paid to the specific needs and potential risks of different populations.
Before using Alpelisib, it is necessary to confirm that the woman is pregnant. Women should use effective contraception during treatment and for a week after taking the drug. Male partners should also use contraception. Animal studies have shown that drugs may affect fertility.
The safety and efficacy of Alpelisib in pediatric patients have not been fully validated. Children and adolescents under the age of 18 should be cautious when using this drug, and treatment under the guidance of a professional doctor is recommended.
After understanding the use of Alpelisib in special populations, patients should also pay attention to the precautions for the use of the drug to help prevent and manage possible adverse effects.
When using Alpelisib, it is necessary to pay special attention to the following precautions to avoid potential adverse reactions and deal with common problems in a timely manner.
In case of serious adverse skin reactions (e.g., SCARs), the drug should be discontinued immediately and a dermatologist should be consulted. Diagnosis of SCAR requires permanent discontinuation of Alpelisib, and dose adjustment may be required to use topical therapy if the diagnosis is not confirmed.
Fasting blood glucose (FPG) and HbA1c are measured prior to treatment, and are monitored weekly for the first two weeks and every four weeks thereafter. High-risk patients require more frequent blood glucose monitoring and treatment adjustments.
These are some of the dos and don'ts of Alpelisib, and following these recommendations can help you better manage the potential risks during your medication.
[Warm tips] Please maintain a good lifestyle during the use of Alpelisib, regularly monitor relevant indicators, and pay attention to your body's reaction.
